This opportunity funds research to develop and validate innovative healthcare interventions aimed at reducing the burden of major non-communicable diseases such as cardiovascular diseases, diabetes, chronic respiratory diseases, and chronic kidney diseases. Funded activities include early-stage clinical trials supported by proof-of-concept data, patient engagement, data sharing according to FAIR principles, and regulatory consultations. Proposals must demonstrate feasibility and address co-morbidities where relevant.
Eligible applicants include legal entities established in eligible countries as described in the Horizon Europe Work Programme General Annexes, including the United States. Applicants must comply with admissibility conditions such as blind evaluation requirements and have the financial and operation
